Cite
Moreno-Viguri E, Jiménez-Montes C, Martín-Escolano R, et al. Correction to In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives. J Med Chem. 2017;60(6):2604doi: 10.1021/acs.jmedchem.7b00263.
Moreno-Viguri, E., Jiménez-Montes, C., Martín-Escolano, R., Santivañez-Veliz, M., Martin-Montes, A., Azqueta, A., Jimenez-Lopez, M., Zamora Ledesma, S., Cirauqui, N., López de Ceráin, A., Marín, C., Sánchez-Moreno, M., & Pérez-Silanes, S. (2017). Correction to In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives. Journal of medicinal chemistry, 60(6), 2604. https://doi.org/10.1021/acs.jmedchem.7b00263
Moreno-Viguri, Elsa, et al. "Correction to In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives." Journal of medicinal chemistry vol. 60,6 (2017): 2604. doi: https://doi.org/10.1021/acs.jmedchem.7b00263
Moreno-Viguri E, Jiménez-Montes C, Martín-Escolano R, Santivañez-Veliz M, Martin-Montes A, Azqueta A, Jimenez-Lopez M, Zamora Ledesma S, Cirauqui N, López de Ceráin A, Marín C, Sánchez-Moreno M, Pérez-Silanes S. Correction to In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives. J Med Chem. 2017 Mar 23;60(6):2604. doi: 10.1021/acs.jmedchem.7b00263. Epub 2017 Mar 03. PMID: 28257207.
Copy
Download .nbib
